SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000827809-18-000032
Filing Date
2018-08-07
Accepted
2018-08-07 16:04:17
Documents
68
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nvln-063018x10q.htm   iXBRL 10-Q 1045409
2 EXHIBIT 10.2 a20180630exhibit102.htm EX-10.2 13976
3 EXHIBIT 31.1 a20180630exhibit311.htm EX-31.1 12377
4 EXHIBIT 31.2 a20180630exhibit312.htm EX-31.2 12364
5 EXHIBIT 32.1 a20180630exhibit321.htm EX-32.1 6025
6 EXHIBIT 32.2 a20180630exhibit322.htm EX-32.2 6141
  Complete submission text file 0000827809-18-000032.txt   4858310

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nvln-20180630.xsd EX-101.SCH 36083
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nvln-20180630_cal.xml EX-101.CAL 69164
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nvln-20180630_def.xml EX-101.DEF 151572
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nvln-20180630_lab.xml EX-101.LAB 398140
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nvln-20180630_pre.xml EX-101.PRE 257556
12 EXTRACTED XBRL INSTANCE DOCUMENT nvln-063018x10q_htm.xml XML 819019
Mailing Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3
Business Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3 (877) 764-3131
NOVELION THERAPEUTICS INC. (Filer) CIK: 0000827809 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-17082 | Film No.: 18997928
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences